Our next meeting which will be this Wednesday October 5th at 7pm. Our planned speaker Sophie Lebel has had to withdraw this week but agreed to reschedule her talk about cancer recurrence, the issues and anxieties to a future date (TBD).

We are very pleased to have Tina Crosbie,Clinical Pharmacist, Hematology at the Ottawa Hospital give a presentation on Daratumumab administered by SubCutaneous injection (which substantially reduces the treatment time compared with IV infusion).

She will cover how Cancer Care Ontario aka Ontario Health is now funding Daratumumab SC for patients in Ontario (after a long delay from the CVOID pandemic).  Tina will also discuss how this is starting to launch at the Ottawa Hospital, and will try to answer your questions about this exciting recent development.